![Guikai George Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Guikai George Wu
Chief Executive Officer at Amberstone Biosciences, Inc.
Guikai George Wu active positions
Companies | Position | Start | End |
---|---|---|---|
Amberstone Biosciences, Inc.
![]() Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Chief Executive Officer | 2017-12-31 | - |
Director of Finance/CFO | 2017-12-31 | - | |
Founder | 2017-12-31 | - | |
President | 2017-12-31 | - |
Career history of Guikai George Wu
Statistics
International
United States | 2 |
Operational
Chief Executive Officer | 1 |
Director of Finance/CFO | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Amberstone Biosciences, Inc.
![]() Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Health Technology |
- Stock Market
- Insiders
- Guikai George Wu
- Experience